Menta Capital’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Menta Capital’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-19,514	Closed	-$87K	–	1070
2016 Q2	$87K	Hold	19,514	–	–	0.01%	826
2016 Q1	$205K	Buy	19,514 +14,014	+255%	+$279K	0.03%	809
2015 Q4	$162K	Buy	5,500 +4,430	+414%	+$134K	0.02%	793
2015 Q3	$34K	Buy	+1,070	New	+$51.2K	0.01%	695
2015 Q1	–	Sell	-1,700	Closed	-$160K	–	868
2014 Q4	$160K	Buy	+1,700	New	+$162K	0.02%	618
2014 Q3	–	Sell	-2,310	Closed	-$207K	–	730
2014 Q2	$207K	Buy	+2,310	New	+$142K	0.04%	462

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Menta Capital's PTX Position: Q3 2016 in Review

Menta Capital sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2016, closing a stake of 19,514 shares — an estimated $87K sold.

Menta Capital first reported a position in PTX in Q2 2014 and held it in 6 quarters. The position peaked at $207K in Q2 2014. 48 funds tracked by Wall St. Rank hold PTX as of Q3 2016.

Menta Capital reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
Menta Capital sold 19,514 Pernix Therapeutics Holdings, Inc. shares in Q3 2016, an estimated $87K.
Menta Capital first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 6 quarters.
Menta Capital's Pernix Therapeutics Holdings, Inc. position peaked at $207K in Q2 2014.
48 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2016.

Based on Menta Capital's 13F filing for Q3 2016, filed 14 Nov 2016.